Abstract:BACKGROUND: Alzheimer's disease (AD) is a dementia, a neurodegenerative condition, and a protein-misfolding disease or proteinopathy, characterized by protein deposits, extracellular plaques and intracellular neurofibrillary tangles, which contain the AD's typical pathological proteins, abnormal β-amyloid and hyperphosphorylated tau, respectively, and are located predominantly in the cortex of the frontal, parietal, and temporal brain lobes. What is the role of molecular chaperones in AD? Data indicate that molecular chaperones, also known as Hsp, are involved in AD, probably displaying protective roles and/or acting as pathogenic factors as it occurs in chaperonopathies in which case AD would be suitable to chaperonotherapy. Hsp60, Hsp70, and Hsp90 can be augmented and overexpressed or diminished and downregulated in various situations in AD affected tissues and cells, indicating they are active during disease development and progression.QUESTION: What is the role of molecular chaperones in AD? Data indicate that molecular chaperones, also known as Hsp, are involved in AD, probably displaying protective roles and/or acting as pathogenic factors as it occurs in chaperonopathies in which case AD would be suitable to chaperonotherapy.OBJECTIVE: Investigate the role of Hsp in AD, focusing on Hsp60, Hsp70, and Hsp90.METHOD: Critical examination of published data.RESULTS: Hsp60, Hsp70, and Hsp90 can be augmented and overexpressed or diminished and downregulated in various situations in AD affected tissues and cells, indicating they are active during disease development and progression.CONCLUSION AND PERSPECTIVES: Notwithstanding that the roles and mechanisms of action of chaperones in AD are still incompletely understood, there is already enough evidence to encourage the development of therapeutic strategies targeting them, either to block their activity in case they promote disease progression or to boost their performance when they are protective. The latter is an example of positive chaperonotherapy, which also includes chaperone replacement via gene or protein administration. On the contrary, if a chaperone is found to help the disease, it has to be blocked or eliminated, which constitute modalities of negative chaperonotherapy.

Alzheimer's Disease and Molecular Chaperones: Current Knowledge and the Future of Chaperonotherapy

Chaperones—A New Class of Potential Therapeutic Targets in Alzheimer's Disease

Molecular Chaperones: A Double-Edged Sword in Neurodegenerative Diseases

The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases

Heat Shock Proteins in Alzheimer’s Disease: Role and Targeting

Updates on Aβ Processing by Hsp90, BRICHOS, and Newly Reported Distinctive Chaperones

Molecular Chaperones as Therapeutic Target: Hallmark of Neurodegenerative Disorders

Molecular Chaperones and Co-Chaperones in Parkinson Disease

Molecular chaperones: Toward new therapeutic tools

Targeting Chaperone/Co-Chaperone Interactions with Small Molecules: A Novel Approach to Tackle Neurodegenerative Diseases

Mechanistic Insights into the Role of Molecular Chaperones in Protein Misfolding Diseases: From Molecular Recognition to Amyloid Disassembly

Molecular Chaperones' Potential against Defective Proteostasis of Amyotrophic Lateral Sclerosis

The Role of HSP70 and Its Co-chaperones in Protein Misfolding, Aggregation and Disease

The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer’s Disease

Deranged Expression of Molecular Chaperones in Brains of Patients with Alzheimer's Disease

Putative Roles and Therapeutic Potential of the Chaperone System in Amyotrophic Lateral Sclerosis and Multiple Sclerosis

Molecular chaperones and protein folding as therapeutic targets in Parkinson’s disease and other synucleinopathies

The therapeutic potential of chemical chaperones in protein folding diseases

Amyloid inhibition by molecular chaperones in vitro can be translated to Alzheimer's pathology in vivo

Roles of molecular chaperones in protein misfolding diseases

Chaperoning Proteins for Destruction: Diverse Roles of Hsp70 Chaperones and their Co-Chaperones in Targeting Misfolded Proteins to the Proteasome